Besides, CD24 had been shown to serve as a candidate unique identifier for CSCs in NB, where a small fraction of CD24+ cells were observed within the high-risk NB tumor-spheres derived from bone marrow aspirates (Hansford et al., 2007). This evidence concerns the gene CD24 and neuroblastoma.